We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+15.5%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.94B
AUM Growth
+$354M
(+14%)
Cap. Flow
+$71.5M
Cap. Flow
% of AUM
2.43%
Top 10 Holdings %
Top 10 Hldgs %
43.94%
Holding
91
New
27
Increased
20
Reduced
25
Closed
12
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$85.5M |
| 2 |
uniQure
QURE
|
+$52M |
| 3 |
Labcorp
LH
|
+$50.7M |
| 4 |
Xeris Biopharma Holdings
XERS
|
+$46.9M |
| 5 |
InflaRx
IFRX
|
+$40.6M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
+$78.7M |
| 2 |
Puma Biotechnology
PBYI
|
+$74.6M |
| 3 |
Penumbra
PEN
|
+$67.6M |
| 4 |
Abbott
ABT
|
+$39.2M |
| 5 |
Regenxbio
RGNX
|
+$27.2M |
Sector Composition
| 1 | Healthcare | 93.19% |
| 2 | Financials | 1.03% |
| 3 | Technology | 0% |
| 4 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
26
DELISTED
Cymabay Therapeutics
CBAY
| $39.7M | 1.35% |
2,957,765
+2,200
| +0.1% | +$27.5K |
|
|
MOR
27
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $38.5M | 1.31% |
+1,269,800
| New | +$34.9M |
|
28
AnaptysBio
ANAB
$1.6B
| $36.9M | 1.25% |
519,250
-3,900
| -0.7% | -$327K |
|
|
HSKA
29
DELISTED
Heska Corp
HSKA
| $36.8M | 1.25% |
354,776
+116,330
| +49% | +$10.9M |
|
30
UnitedHealth
UNH
$392B
| $35.1M | 1.19% |
143,020
-2,400
| -2% | -$576K |
|
31
Elevance Health
ELV
$81.9B
| $34.8M | 1.18% |
+146,000
| New | +$33.8M |
|
|
CBIO
32
Crescent Biopharma
CBIO
$425M
| $32.7M | 1.11% |
20,293
-2,530
| -11% | -$4.35M |
|
33
iRhythm Holdings
IRTC
$3.81B
| $32.6M | 1.11% |
401,303
-328,571
| -45% | -$23M |
|
34
eHealth
EHTH
$48.2M
| $30.5M | 1.03% |
1,377,895
+47,400
| +4% | +$914K |
|
|
OXFD
35
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $28.8M | 0.98% |
2,235,207
-234,480
| -9% | -$3.17M |
|
|
NITE
36
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $28.6M | 0.97% |
1,785,446
+16,500
| +0.9% | +$235K |
|
|
CTLT
37
DELISTED
CATALENT, INC.
CTLT
| $27.7M | 0.94% |
+661,850
| New | +$26.7M |
|
|
38
Abbott
ABT
$172B
| $27.4M | 0.93% |
449,300
-646,800
| -59% | -$39.2M |
|
|
EPZM
39
DELISTED
Epizyme, Inc
EPZM
| $27.4M | 0.93% |
2,021,389
+9,400
| +0.5% | +$146K |
|
40
Scholar Rock
SRRK
$6.12B
| $27.3M | 0.93% |
+1,750,408
| New | +$32.8M |
|
|
ELGX
41
DELISTED
Endologix Inc
ELGX
| $24.5M | 0.83% |
432,639
-159,677
| -27% | -$8.1M |
|
42
Teleflex
TFX
$6.02B
| $21.4M | 0.73% |
79,886
-96,700
| -55% | -$25.9M |
|
43
Zoetis
ZTS
$32.4B
| $21.2M | 0.72% |
+249,100
| New | +$21M |
|
|
CMRX
44
DELISTED
Chimerix, Inc.
CMRX
| $17.1M | 0.58% |
3,589,490
-139,200
| -4% | -$665K |
|
|
SYRS
45
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $16.7M | 0.57% |
163,124
-2,100
| -1% | -$260K |
|
|
TCDA
46
DELISTED
Tricida, Inc. Common Stock
TCDA
| $14.9M | 0.51% |
+500,000
| New | +$14M |
|
|
ODT
47
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $13.5M | 0.46% |
610,600
+16,400
| +3% | +$382K |
|
48
Teladoc Health
TDOC
$1.74B
| $13.4M | 0.46% |
231,000
-42,200
| -15% | -$2.06M |
|
|
49
Penumbra
PEN
$12.5B
| $9.97M | 0.34% |
72,170
-474,909
| -87% | -$67.6M |
|
|
JNCE
50
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $9.3M | 0.32% |
1,214,593
+32,200
| +3% | +$464K |
|
Similar funds
ORI
KP
HCMG
FMI
FCM
SCM
PP
AM